Skip to main content Skip to footer

Insights

Thought Leadership, Founder Perspectives, and Industry News and Press

Filter

20 Results Reset

Adovate Closes $6 Million Round Oversubscribed

Member Announcements Aug 4, 2025

Adovate Closes $6 Million Round Oversubscribed

AstraZeneca unveils $50 billion US investment as pharma tariff threat looms

Member Announcements Jul 23, 2025

AstraZeneca unveils $50 billion US investment as pharma tariff threat looms

Why Everyone’s Betting on Virginia: The New U.S. Capital of Innovation

Member Announcements Jun 8, 2025

Why Everyone’s Betting on Virginia: The New U.S. Capital of Innovation

BIO-CAT Gains Organic Certification to Meet the Growing Demands of Consumers

Member Announcements Jun 3, 2025

BIO-CAT Gains Organic Certification to Meet the Growing Demands of Consumers

Member Announcements Jun 3, 2025

PS Fertility Announces Successful Completion of Series A Funding

Adovate Accepted into JLABS, Global Incubator Network

Member Announcements Jun 3, 2025

Adovate Accepted into JLABS, Global Incubator Network

BrightSpec Announces $18.4 Million Financing Round Led by Genoa Ventures and Arboretum Ventures

Member Announcements Dec 14, 2022

BrightSpec Announces $18.4 Million Financing Round Led by Genoa Ventures and Arboretum Ventures

Adial Pharmaceuticals Names Cary Claiborne as Chief Executive Officer

Member Announcements Aug 30, 2022

Adial Pharmaceuticals Names Cary Claiborne as Chief Executive Officer

HemoShear Therapeutics Appoints Brian Wamhoff, PhD, Interim Chief Executive Officer

Member Announcements Aug 30, 2022

HemoShear Therapeutics Appoints Brian Wamhoff, PhD, Interim Chief Executive Officer

HemoShear Therapeutics Raises $40 Million in Series A Financing to Advance Rare Disease Portfolio

Member Announcements Feb 10, 2021

HemoShear Therapeutics Raises $40 Million in Series A Financing to Advance Rare Disease Portfolio

Apply for Membership